BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 4, 2008
View Archived Issues
Amitriptyline beneficial in benign prostatic hyperplasia
Read More
AstraZeneca develops 5-HT1B receptor radioligand for PET imaging
Read More
Notch inhibition with MRK-003 active in preclinical pancreatic cancer experiments
Read More
Recent GSK, Pfizer and Roche patents disclose new antipsychotic agents
Read More
Novel therapeutic agents for respiratory and allergic disorders described in recent patents
Read More
Recent Bayer and Takeda patents disclose novel compounds for cardiovascular disorders
Read More
Snapshots: Recent data on immunoconjugates from ImmunoGen
Read More
Interim results from a phase I solid tumor study with weekly EZN-2968
Read More
GlaxoSmithKline: Q3 review
Read More
FDA accepts IND for ART-621, Arana to commence phase II studies
Read More
PAION reports successful meta-analysis for pain drug M6G
Read More
Synosia starts phase IIa nepicastat trial in post-traumatic stress disorder
Read More
TMC-207 shows promise as a treatment for tuberculosis
Read More
FDA approves donated blood screening test for HIV, HCV and HBV
Read More
FDA approves Treanda for relapsed indolent non-Hodgkin's lymphoma
Read More
Mpex initiates phase II clinical trial of aerosol MP-376 in COPD
Read More
Neoprobe receives positive EMEA response to RIGScan CR submission
Read More
ProStrakan launches Sancuso in U.S. for chemotherapy-induced nausea
Read More
Welichem reports phase IIa results for WBI-1001 atopic dermatitis cream
Read More
BioMarin commences clinical assessment program for Morquio A syndrome
Read More
MedImmune commences phase I/IIa trial for respiratory syncytial virus vaccine
Read More
Portola starts phase II betrixaban trial for stroke prevention in atrial fibrillation
Read More
Medarex and MBL report results from phase II trial of MDX-066 and MDX-1388
Read More
AEterna Zentaris initiates second stage of patient recruitment in phase II trial of AEZS-108
Read More
Canopus reports results from specialized laboratory study of peptide cancer vaccine
Read More
Cel-Sci expands licensing agreement for cancer drug Multikine to Orient Europharma
Read More